BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gómez-gutiérrez C, Chávez-tapia NC, Ponciano-rodríguez G, Uribe M, Méndez-sánchez N. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America. Annals of Hepatology 2015;14:807-14. [DOI: 10.5604/16652681.1171751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Deshpande R, Stepanova M, Golabi P, Brown K, Younossi ZM. Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units. J Viral Hepat 2019;26:1293-300. [PMID: 31294521 DOI: 10.1111/jvh.13173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Villar LM, Cruz HM, Portilho MM, Barbosa JR, Mendonça ACFD, Flores GL. Emergence of New Epidemiological Hepatitis B and C Profiles in High Risk Groups in Latin America. In: Majumder MAA, Kabir R, Rahman S, editors. Public Health - Emerging and Re-emerging Issues. InTech; 2018. [DOI: 10.5772/intechopen.79174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Pereson MJ, Martínez AP, Isaac K, Laham G, Ridruejo E, Garcia GH, Flichman DM, Di Lello FA. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina. J Med Microbiol 2021;70. [PMID: 33180017 DOI: 10.1099/jmm.0.001278] [Reference Citation Analysis]
4 Ajlan AA, Al-Gain R, Ahmed M, Abu-Riash T, Alquaiz M, Alkhail FA, Alashgar H, Alkhairallah T, Alkortas D, Al-Jedai A. Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program. J Am Pharm Assoc (2003) 2021;61:e159-70. [PMID: 33309191 DOI: 10.1016/j.japh.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Neukam K, Ridruejo E, Pérez P, Campos RH, Martínez AP, Di Lello FA. Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups. Eur J Clin Microbiol Infect Dis 2018;37:247-54. [PMID: 29076048 DOI: 10.1007/s10096-017-3123-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Lai TS, Lee MH, Yang HI, You SL, Lu SN, Wang LY, Yuan Y, L'Italien G, Chien KL, Chen CJ;  REVEAL-HCV Study Group. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study. Hepatology. 2017;66:784-793. [PMID: 28370058 DOI: 10.1002/hep.29192] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
7 Cabezas C, Trujillo O, Gonzales-Vivanco Á, Benites Villafane CM, Balbuena J, Borda-Olivas AO, Suarez-Jara MA, Peceros FM, Ramírez-Soto MC. Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS One 2020;15:e0234273. [PMID: 32542052 DOI: 10.1371/journal.pone.0234273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]